What is GraphWear Technologies?
GraphWear Technologies specializes in developing pain-free, innovative solutions for glucose management, aiming to significantly enhance the user experience for individuals managing diabetes. The company's technology is designed to offer a more comfortable and efficient method for monitoring glucose levels, thereby improving the overall quality of life for its target clientele. By focusing on user-centric design and advanced technological integration, GraphWear is positioning itself as a key player in the evolving landscape of diabetes care.
How much funding has GraphWear Technologies raised?
GraphWear Technologies has raised a total of $24.7M across 2 funding rounds:
Series A
$4.2M
Series B
$20.5M
Series A (2018): $4.2M with participation from Mission Bay Capital and BioInnovation Capital
Series B (2021): $20.5M led by Builders VC, BioInnovation Capital, Mayfield, and VSC Ventures
Key Investors in GraphWear Technologies
Builders VC
Builders VC is a venture capital firm that invests in innovative technologies and solutions aimed at modernizing antiquated industries. They support founders tackling complex problems across sectors like healthcare and aim to reshape systems.
BioInnovation Capital
BioInnovation Capital specializes in in vitro testing, research, development, and consulting services for clients in the pharmaceutical, cosmetic, personal health care, and specialty chemical industries, offering innovative solutions tailored to client needs.
Mayfield
Mayfield is a venture capital firm that invests in early-stage technology companies, primarily at seed and Series A, backing enterprise, consumer, and infrastructure founders and partnering with them through growth and exit.
What's next for GraphWear Technologies?
The recent major strategic investment in GraphWear Technologies signals a pivotal moment for the company, likely enabling accelerated product development, market expansion, and enhanced research initiatives. This capital infusion is expected to fuel the scaling of their operations and further refine their innovative glucose management solutions. The company's focus on improving the lives of individuals with diabetes, coupled with significant backing, suggests a strong potential for future breakthroughs and market leadership in the health-tech sector.
See full GraphWear Technologies company page
